Therefore, Romidepsin datasheet we used The Health Improvement Network (THIN), a UK database of anonymized electronic primary care records to derive our study population. THIN has been shown to have a high validity of recorded diagnoses, medical events, and prescriptions.18 It has been used previously to assess fertility problem reporting at a population level,19 and the overall and age-specific fertility rates in THIN are broadly comparable with national fertility rates.20 The version of THIN used for the purpose of this study contained longitudinal records of prospectively collected health information from 570 general practices across

the United Kingdom, covering 6% of the total UK population.21 Our cohort included all women of potential childbearing

age (15–49 y) who contributed 1 or more years of active registration time between January 1990 and January 2013 to a general practice providing data to THIN. We selected women aged 15–49 years in accordance with the World Health Organization denominator for calculating the prevalence of infertility in women.22 We identified each woman as having CD if she had a recorded diagnosis of CD in her general practice record using Read codes (clinically coded thesauraus used by general practitioners in the UK to record medical information) (Read codes: J690.00 for CD, J690.13 for gluten enteropathy, J690.14 for sprue-nontropical, J690100 for acquired CD, and J690z00 for CD NOS) with or without 4-Aminobutyrate aminotransferase accompanying evidence of either gluten-free dietary prescriptions

or dermatitis herpetiformis. Each woman with CD was assigned a date of diagnosis corresponding EPZ015666 order to the date of her first record of CD or the date of her first prescription of a gluten-free product (if present). Women with CD were classified further as having the diagnosis after the first fertility problem record (undiagnosed CD) or before (diagnosed CD). The method used to define CD has been validated previously in general practice databases with a positive predictive value ranging between 81% and 89%.23 Lastly, we used longitudinally recorded information on women’s disease symptoms and biological measurements (weight loss, diarrhea, or anemia in the year before celiac disease diagnosis) to give a proxy metric for women with more severe symptomatic CD. Our comparison group consisted of women of childbearing age without any recorded diagnoses of CD or dermatitis herpetiformis in their primary care data. Women who received a gluten-free prescription in the absence of any CD or dermatitis herpetiformis diagnosis at any point during the study period also were excluded. Fertility problems in women were defined using read codes for fertility investigations (eg, 3189.00 for infertility investigation female), interventions (eg, 7M0h.00 for in vitro fertilization), specific (eg, K5B0000 for primary anovulatory infertility) or nonspecific diagnoses (eg, 1AZ2.